Loading...
•
Dec 31, 2024
Acadia Healthcare Q4 2024 Earnings Report
Acadia Healthcare reported solid revenue growth in Q4 2024, though earnings declined due to higher expenses.
Key Takeaways
Acadia Healthcare's Q4 2024 revenue increased by 4.2% year-over-year to $774.2 million, driven by higher patient volumes and growth in same-facility revenue. However, net income declined to $32.6 million, impacted by increased operating expenses and facility-related costs. Adjusted EPS came in at $0.64, while adjusted EBITDA totaled $153.1 million, reflecting a $14.3 million professional liability reserve adjustment and a $5.0 million impact from facility closures.
Total revenue increased by 4.2% year-over-year to $774.2 million.
Same-facility revenue grew by 4.7%, driven by a 3.2% increase in patient days.
Net income declined to $32.6 million, impacted by higher costs and facility closures.
Adjusted EPS improved to $0.64, while adjusted EBITDA reached $153.1 million.
Acadia Healthcare
Acadia Healthcare
Forward Guidance
Acadia Healthcare expects continued revenue growth in 2025, with stable margins and expansion in patient capacity.
Positive Outlook
- Full-year 2025 revenue projected between $3.3 billion and $3.4 billion.
- Adjusted EBITDA expected to be in the range of $675 million to $725 million.
- Adjusted EPS guidance set at $2.50 to $2.80.
- Expansion plans include adding 800 to 1,000 new beds.
- Continued investments in joint ventures and technology to drive growth.
Challenges Ahead
- Interest expense expected to increase to $130 million to $140 million.
- Depreciation and amortization expenses projected at $175 million to $185 million.
- Startup losses for newly opened facilities expected to rise to $50 million to $55 million.
- Potential net decrease in Medicaid supplemental payments of up to $15 million.
- Expansion capital expenditures projected to be between $525 million and $575 million.